Clearside Biomedical CLSD reported its Q2 earnings results on Tuesday, August 9, 2022.
Here's what investors need to know about the announcement.
Earnings
Clearside Biomedical reported in-line EPS of $-0.13 versus an estimate of $-0.13.
Revenue was down $396 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.05 which was followed by a 6.21% drop in the share price the next day.
Here's a look at Clearside Biomedical's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.08 | 0.16 | -0.08 | -0.12 |
EPS Actual | -0.13 | 0.31 | -0.08 | -0.11 |
Revenue Estimate | 2.87M | 17.77M | 2.58M | 690K |
Revenue Actual | 347K | 25.69M | 3.07M | 780K |
To track all earnings releases for Clearside Biomedical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.